Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes

Scientists are exploring new ways to treat diabetes by focusing on the pancreas, which normally contains about a billion insulin-producing beta cells. In people with diabetes, these cells are either absent or not working properly. Researchers have made progress by genetically altering another type of pancreatic cell, called ductal cells, to produce insulin. They discovered that by turning off a gene called ALDH3B2, more ductal cells could transform into insulin-producing cells. This was tested in mice, where human insulin was produced, and blood sugar levels improved. This approach could offer a new way to treat diabetes by using the body’s existing cells, though it requires precise targeting to avoid affecting other cells. This research is part of broader efforts to find long-term solutions for diabetes, including gene therapies and lab-grown cells. QUESTION: How might advancements in genetic engineering change the way we treat diseases like diabetes in the future?